Changing incidence of non-melanoma skin cancer in New Zealand

被引:38
|
作者
Brougham, Nicholas D. L. [1 ,2 ]
Dennett, Elizabeth R. [2 ]
Tan, Swee T. [1 ,2 ,3 ]
机构
[1] Hutt Hosp, Wellington Reg Plast Maxillofacial & Burns Unit, Lower Hutt, New Zealand
[2] Univ Otago, Wellington Sch Med & Hlth Sci, Wellington, New Zealand
[3] Gillies McIndoe Res Inst, Wellington, New Zealand
关键词
basal cell carcinoma; incidence; non-melanoma; skin cancer; squamous cell carcinoma; SUN EXPOSURE; AUSTRALIAN ADOLESCENTS; BASAL-CELL; TRENDS; EPIDEMIOLOGY; CARCINOMA; BEHAVIORS;
D O I
10.1111/j.1445-2197.2010.05583.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) are the commonest types of non-melanoma skin cancer (NMSC). The incidence of NMSC has been increasing globally with Australia recording a 1.5-fold increase over the last 17 years. The incidence of NMSC in New Zealand is currently unknown. Given that Australia and New Zealand share similar latitude, sun exposure levels, and other risk factors, it is conceivable this increase has also occurred in New Zealand. This study aimed to provide an analysis of the incidence of NMSC within the Central Region of New Zealand based on longitudinal data derived from pathology reports. Methods: This retrospective study examined the pathology records of 26 411 patients who underwent surgical excision for 54 004 NMSC lesions which were histologically confirmed, over a 10-year period from 1 January, 1997 to 1 January, 2007, within the Central Region of New Zealand. Results: Over the study period, 50 411 primary NMSC lesions were excised. The age-standardized incidence for NMSC, BCC and SCC was 406, 299 and 118 per 100 000, respectively. Since 1999, the annual incidence of BCC and SCC has increased by 4.0% and 1.1%, respectively, with the greatest increases seen in the population over the age of 50 years. Conclusion: New Zealand has one of the highest incidence of NMSC in the world. The high and increasing incidence of NMSC underscores the importance for the development and implementation of a national health-care delivery model, and a commitment to continued monitoring of the NMSC problem.
引用
收藏
页码:633 / 636
页数:4
相关论文
共 50 条
  • [31] NON-MELANOMA SKIN-CANCER
    DUVIVIER, A
    [J]. PRACTITIONER, 1984, 228 (1392) : 549 - 553
  • [32] NON-MELANOMA SKIN-CANCER
    MORA, RG
    [J]. PRIMARY CARE, 1989, 16 (03): : 665 - 684
  • [33] Risk of subsequent non-melanoma skin cancers in patients with prior non-melanoma skin cancer
    Wehner, M. R.
    Linos, E.
    Parvataneni, R.
    Stuart, S. E.
    Boscardin, W. J.
    Chren, M.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2013, 133 : S93 - S93
  • [34] Immunotherapy for Non-melanoma Skin Cancer
    Sophia Z. Shalhout
    Kevin S. Emerick
    Howard L. Kaufman
    David M. Miller
    [J]. Current Oncology Reports, 2021, 23
  • [35] NON-MELANOMA SKIN-CANCER
    HARVEY, I
    SHALOM, D
    MARKS, RM
    FRANKEL, SJ
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1989, 299 (6708): : 1118 - 1120
  • [36] Welding and non-melanoma skin cancer
    Currie, CLA
    Monk, BE
    [J]. CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2000, 25 (01) : 28 - 29
  • [37] Non-Melanoma Skin Cancer - Overview
    Joseph, Kurian
    [J]. CURRENT CANCER THERAPY REVIEWS, 2016, 12 (03) : 142 - 151
  • [38] NON-MELANOMA SKIN CANCER Introduction
    Rohrer, Thomas E.
    [J]. SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 2011, 30 (01) : 1 - 2
  • [39] Immunotherapy for Non-melanoma Skin Cancer
    Shalhout, Sophia Z.
    Emerick, Kevin S.
    Kaufman, Howard L.
    Miller, David M.
    [J]. CURRENT ONCOLOGY REPORTS, 2021, 23 (11)
  • [40] NON-MELANOMA SKIN-CANCER
    PICKLES, T
    [J]. BRITISH MEDICAL JOURNAL, 1989, 299 (6713): : 1464 - 1464